A Way Around | GenomeWeb

A Way Around

Messenger RNAs are once again capturing the attention of pharmaceutical companies as a class of drugs, writes Susan Young at MIT's Technology Review. In the past, mRNAs had garnered interest, but then had been abandoned as they can also set off an immune response.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.